Toggle navigation
Home
Search
Services
Blog
Contact
About
Testing in vivo of HIV-immunopathogenic hypotheses using new kinetic techniques
Hellerstein, Marc Kopel
University of California Berkeley, Berkeley, CA, United States
Search 163 grants from Marc Hellerstein
Search grants from University of California Berkeley
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
PROSPR Statistical Coordinating Center (PSCC)
Development of an Artificial Pump-Lung for Respiratory Failure
The Roles of Costimulatory Molecules in EAAU
Targeting Stealth Liposome for Cancer Gene Therapy
Regulation of Adrenal C19 Steroid Biosynthesis
Recently added grants:
Development of Next Generation Galeterone Analogs for Prostate Cancer Therapy
Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer
Defining the contributions of BRCA1, BRCA2, and RAD52 to genome stability
Targeting Oncogenic Ras-MAPK Signaling Complexes via the Scaffold KSR
Radiotherapy-associated breast cancer: machine learning on genotypes to predict individualized risk
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37AI043866-13
Application #
7799772
Study Section
Special Emphasis Panel (NSS)
Program Officer
Bridges, Sandra H
Project Start
1998-01-01
Project End
2013-03-31
Budget Start
2010-04-01
Budget End
2011-03-31
Support Year
13
Fiscal Year
2010
Total Cost
$437,985
Indirect Cost
Institution
Name
University of California Berkeley
Department
Nutrition
Type
Schools of Earth Sciences/Natur
DUNS #
124726725
City
Berkeley
State
CA
Country
United States
Zip Code
94704
Related projects
Publications
Veerapathran, Anandharaman; Pidala, Joseph; Beato, Francisca et al.
(2013)
Human regulatory T cells against minor histocompatibility antigens: ex vivo expansion for prevention of graft-versus-host disease.
Blood 122:2251-61
Comments
Be the first to comment on Marc Hellerstein's grant